Inventor · disambiguated record
Liqiang Fu
Also filed as: FU LIQIANG
6 granted patents·8 pending applications·6 citations·filing 2017–2023
68Inventor score
Files withJANSSEN PHARMACEUTICA NV7HANGZHOU GLUBIO PHARMACEUTICAL CO LTD3GENENTECH INC2ABBVIE INC1BEIJING AEROSPACE KAIEN NEW & ADVANCED MAT CO LTD1
Top patents by PatentIndex Score
14 records- 0183US11396517B1Exo-aza spiro inhibitors of menin-MLL interactionJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 26, 2022·6 cites·13 claims
- 0257US2023039917A1Exo-aza spiro inhibitors of menin-mll interactionJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0355US2025302840A1Combination therapiesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0455US2025333421A1Pyridazines or 1,2,4-triazines substituted by spirocyclic aminesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0554US12473295B2Substituted straight chain spiro derivativesJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 18, 2025·0 cites·20 claims
- 0654US12465103B2Comfortable lightweight bullet-proof and stab-resistant suit and preparation method thereofBEIJING AEROSPACE KAIEN NEW & ADVANCED MAT CO LTD·Filed 2023·Granted Nov 11, 2025·0 cites·20 claims
- 0754US2025049798A1Wee1 protein kinase degradation agent and use thereofHANGZHOU GLUBIO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0854US2024360150A1Isoindolinone compounds and uses thereofHANGZHOU GLUBIO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0953US2024261292A1Combination therapiesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1051US11034698B2Pyrazolo[ 1,5a]pyrimidine derivatives as IRAK4 modulatorsGENENTECH INC·Filed 2019·Granted Jun 15, 2021·0 cites·16 claims
- 1148US11639350B2Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis B infectionsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted May 2, 2023·0 cites·23 claims
- 1246US2024294500A1Isoindolinone compounds, and uses thereofHANGZHOU GLUBIO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1344US10899772B2IRAK4 modulatorsGENENTECH INC·Filed 2019·Granted Jan 26, 2021·0 cites·14 claims
- 1436US2019119200A1Tertiary amides and method of useABBVIE INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Liqiang Fu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →